drugset / Trial / NCT04044729

Mechanisms of CBD for Chronic Pain

NCT04044729

Phase 0 Completed 24 enrolled University of Utah
RandomizedCrossoverDouble-blindTreatment

Summary

This is a study designed to examine the neurochemical mechanisms associated with Cannabidiol (CBD) versus placebo for chronic non-cancer pain.

Timeline

Start
2020-03-16
Primary completion
2024-12-01
Completion
2024-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cannabidiol Other / unclassified 500 mg Oral

Indications